![]()
Boston Business Journal (blog)
![]()
ASCO '15: ImmunoGen Finds Redemption in Strong Ovarian Cancer Drug ResultsTheStreet.comCHICAGO (TheStreet) -- The knock on ImmunoGen (IMGN - Get Report) has long been that early success with its "smart bomb" cancer drug delivery technology wasn't being replicated. At this weekend's ASCO meeting, however, the company's lead pipeline ...ImmunoGen's results in ovarian cancer described as 'impressive' by analystBoston Business Journal (blog)6 Key Cancer Winners From ASCO Presentations24/7 Wall St.Immunogen (IMGN) IMGN853 Data in Platinum-Resistant Ovarian Cancer ...StreetInsider.comall 22 news articles »